Suppr超能文献

翅果油树乙醇提取物通过下调 uPA、MMP-2、MMP-9 和 TIMP-1 的表达来减轻四氯化碳诱导的大鼠肝纤维化。

Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.

机构信息

Graduate Institute of Chinese Pharmaceutical Sciences, College of Pharmacy, China Medical University, Taichung, Taiwan, ROC.

出版信息

J Ethnopharmacol. 2010 Feb 17;127(3):606-13. doi: 10.1016/j.jep.2009.12.016. Epub 2009 Dec 24.

Abstract

AIM OF THE STUDY

To investigate the effect of Fraxinus rhynchophylla ethanol extract (FR(EtOH)) on liver fibrosis induced by carbon tetrachloride (CCl(4)) in rats.

MATERIALS AND METHODS

Rat hepatic fibrosis was induced by oral administration of CCl(4). Sixty SD rats were divided randomly into 6 groups: control, CCl(4) group, silymarin group and three FR(EtOH)-treated groups. Except for the rats in control group, all rats were administered orally with CCl(4) (20%, 0.2 mL/100g body weight) twice a week for 8 weeks. Rats in FR(EtOH) groups were treated daily with FR(EtOH) (0.1, 0.5 and 1.0 g/kg, p.o.) throughout the whole experimental period. Liver function parameters (such as activities of serum GOT and GPT levels), activities of liver anti-oxidant enzymes (such as catalase, SOD, GPx) and expressions of uPA, tPA, MMP-2, MMP-9 and TIMP-1, -2, -3, -4 in the liver fibrosis pathway were detected.

RESULTS

The results showed that FR(EtOH) (0.1, 0.5 and 1.0 g/kg BW) significantly reduced the elevated activities of sGOT and sGPT caused by CCl(4). FR(EtOH) (0.1 and 0.5 g/kg BW) and significantly increased the activities of GSH-Px. The histopathological study showed that FR(EtOH) (0.1 and 0.5 g/kg BW) reduced the incidence of liver lesions, including hepatic cells cloudy swelling, lymphocytes infiltration, cytoplasm vacuolization hepatic necrosis and fibrous connective tissue proliferated induced by CCl(4) in rats. In our study it was showed that CCl(4)-treated group significantly increased the protein levels of uPA, MMP-2, MMP-9 and TIMP-1. FR(EtOH) (0.1 and 0.5 g/kg BW) could inhibit the protein levels of uPA, MMP-2, MMP-9 and TIMP-1. Finally, the amount of esculetin in the FR(EtOH) was 33.54 mg/g extract.

CONCLUSIONS

Oral administration of FR(EtOH) significantly reduces CCl(4)-induced hepatic fibrosis in rats, probably by exerting a protective effect against hepatocellular fibrosis by its free radical scavenging ability. FR(EtOH) down-regulated the expressions of uPA, MMP-2 and MMP-9 in CCl(4)-induced liver fibrosis in rats.

摘要

目的

研究水曲柳乙醇提取物(FR(EtOH))对四氯化碳(CCl(4))诱导的大鼠肝纤维化的影响。

材料与方法

采用 CCl(4)灌胃诱导大鼠肝纤维化。将 60 只 SD 大鼠随机分为 6 组:对照组、CCl(4)组、水飞蓟素组和 3 个 FR(EtOH)处理组。除对照组大鼠外,其余大鼠每周两次口服给予 CCl(4)(20%,0.2 mL/100g 体重),共 8 周。FR(EtOH)组大鼠在整个实验期间每日给予 FR(EtOH)(0.1、0.5 和 1.0 g/kg,po)。检测肝功能参数(如血清 GOT 和 GPT 水平)、肝抗氧化酶活性(如过氧化氢酶、SOD、GPx)以及 uPA、tPA、MMP-2、MMP-9 和 TIMP-1、-2、-3、-4 在肝纤维化途径中的表达。

结果

结果表明,FR(EtOH)(0.1、0.5 和 1.0 g/kg BW)可显著降低 CCl(4)引起的 sGOT 和 sGPT 升高。FR(EtOH)(0.1 和 0.5 g/kg BW)可显著提高 GSH-Px 活性。组织病理学研究表明,FR(EtOH)(0.1 和 0.5 g/kg BW)可降低 CCl(4)诱导的大鼠肝损伤发生率,包括肝细胞浑浊肿胀、淋巴细胞浸润、细胞质空泡化、肝坏死和纤维结缔组织增生。在我们的研究中,发现 CCl(4)处理组 uPA、MMP-2、MMP-9 和 TIMP-1 的蛋白水平显著升高。FR(EtOH)(0.1 和 0.5 g/kg BW)可抑制 uPA、MMP-2、MMP-9 和 TIMP-1 的蛋白水平。最后,FR(EtOH)中的瑞香素含量为 33.54mg/g 提取物。

结论

口服 FR(EtOH)可显著减轻 CCl(4)诱导的大鼠肝纤维化,可能通过其清除自由基能力发挥对肝细胞纤维化的保护作用。FR(EtOH)下调 CCl(4)诱导的大鼠肝纤维化中 uPA、MMP-2 和 MMP-9 的表达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验